Status:
COMPLETED
Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants
Lead Sponsor:
Bnai Zion Medical Center
Conditions:
Bronchiolitis
Eligibility:
All Genders
1-12 years
Phase:
PHASE1
Brief Summary
We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.
Eligibility Criteria
Inclusion
- Age: 0-12 months.
- Infants who are otherwise healthy
- Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
- Parents signed a written informed consent.
Exclusion
- • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00261937
Start Date
December 1 2005
End Date
April 1 2006
Last Update
February 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bnai Zion Medical Center and Naharia Galilli Medical Center
Haifa, Israel, 31048